Kineziterapija namuose - Company finances
|
EUR
|
2022
From: 2022-06-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|
|
Financial data
|
||||
| Sales revenue | 5,388 | 9,725 | 11,185 | 16,310 |
| Profit before tax | 1,008 | 965 | 985 | 3,810 |
| Net profit | 1,008 | 917 | 936 | 3,581 |
| Equity | 1,009 | 1,926 | 2,862 | 2,862 |
| Liabilities | 0 | 0 | 0 | 0 |
| Non-current assets | 0 | 0 | 0 | 0 |
| Current assets | 1,009 | 1,926 | 2,862 | 2,862 |
| Total assets | 1,009 | 1,926 | 2,862 | 2,862 |
|
Taxes paid
|
||||
| STI taxes | - | 657 | 1,362 | 1,579 |
|
Financial indicators
|
||||
| Revenue change y/y | - | +80.5% | +15.0% | +45.8% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 99.9% | 47.6% | 32.7% | 125.1% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 99.9% | 47.6% | 32.7% | 125.1% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 18.7% | 9.4% | 8.4% | 22.0% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | 18.7% | 9.9% | 8.8% | 23.4% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | - | - | - | - |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | - | - | - | - |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Kineziterapija namuose - Social security debts
The amount of overdue SODRA debt for the company Kineziterapija namuose as of the last working day is: 241 €
| From | To | Debt, € |
|---|---|---|
| 2026-09-05 | 2026-09-15 | 241.44 |
| 2026-09-01 | 2026-09-02 | 241.44 |
| 2026-08-26 | 2026-08-31 | 160.96 |
| 2026-08-23 | 2026-08-23 | 160.96 |
| 2026-08-19 | 2026-08-19 | 160.96 |
| 2026-08-16 | 2026-08-17 | 160.96 |
| 2026-08-01 | 2026-08-14 | 160.96 |
| 2026-07-01 | 2026-07-31 | 80.48 |
| 2026-05-03 | 2026-05-31 | 394.37 |
| 2026-04-01 | 2026-04-30 | 313.89 |
| 2026-03-03 | 2026-03-31 | 233.41 |
| 2026-02-03 | 2026-03-02 | 152.93 |
| 2026-01-01 | 2026-02-02 | 72.45 |
| 2025-11-01 | 2025-11-30 | 72.45 |
| 2025-09-02 | 2025-09-30 | 434.70 |
| 2025-08-01 | 2025-09-01 | 362.25 |
| 2025-07-01 | 2025-07-31 | 289.80 |
| 2025-06-03 | 2025-06-30 | 217.35 |
| 2025-05-04 | 2025-06-02 | 144.90 |
| 2025-04-01 | 2025-04-30 | 72.45 |
| 2025-02-11 | 2025-02-28 | 201.45 |
| 2025-02-10 | 2025-02-10 | 129.00 |
| 2025-02-01 | 2025-02-09 | 201.45 |
| 2025-01-02 | 2025-01-31 | 129.00 |
| 2024-12-03 | 2024-12-31 | 64.50 |
| 2024-10-01 | 2024-10-31 | 322.50 |
| 2024-09-03 | 2024-09-30 | 258.00 |
| 2024-08-01 | 2024-09-02 | 193.50 |
| 2024-07-02 | 2024-07-31 | 129.00 |
| 2024-06-03 | 2024-07-01 | 64.50 |
| 2024-03-01 | 2024-03-31 | 64.50 |
| 2024-01-03 | 2024-01-31 | 58.63 |
| 2023-09-01 | 2023-10-31 | 58.63 |
| 2023-06-01 | 2023-06-30 | 175.89 |
| 2023-05-04 | 2023-05-31 | 117.26 |
| 2023-05-02 | 2023-05-03 | 58.63 |
| 2023-04-03 | 2023-04-30 | 58.63 |
| 2023-01-03 | 2023-01-31 | 101.90 |
| 2022-12-01 | 2023-01-02 | 50.95 |
| 2022-10-03 | 2022-10-31 | 50.95 |
| 2022-08-02 | 2022-09-30 | 50.95 |
| 2022-07-01 | 2022-07-31 | 50.95 |
Kineziterapija namuose - VMI tax arrears
| From | To | Overdue, € |
|---|---|---|
| 2025-01-18 | 2025-02-03 | 1530.0 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Kineziterapija namuose, MB (code 306089076) is a Lithuanian small partnership operating in nursing and midwifery activities. In 2025, the company generated revenue of €16.3K, up from €11.2K in 2024 and €9.7K in 2023, showing steady growth over the last three years. Net profit also improved, rising from €917 in 2023 to €936 in 2024 and €3.6K in 2025. Profit margin strengthened to 22.0% in 2025, compared with 8.4% in 2024 and 9.4% in 2023. The balance sheet remained very small, with total assets and equity both at €2.9K in 2025, and the equity ratio at 100.0%. Asset turnover reached 5.70x, indicating high revenue generation relative to the asset base. The company’s return measures were elevated because they were calculated from a very small equity and asset base, so they should be interpreted in that context rather than as a scale indicator.